Eldridge Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
9,757
+524
| +6% | +$97.3K | 0.38% | 53 |
|
|
2025
Q1 | $1.93M | Buy |
9,233
+5
| +0.1% | +$1.05K | 0.45% | 51 |
|
|
2024
Q4 | $1.64M | Sell |
9,228
-409
| -4% | -$72.7K | 0.38% | 58 |
|
|
2024
Q3 | $1.9M | Buy |
9,637
+4
| +0% | +$790 | 0.45% | 52 |
|
|
2024
Q2 | $1.65M | Buy |
9,633
+609
| +7% | +$104K | 0.42% | 56 |
|
|
2024
Q1 | $1.64M | Buy |
9,024
+33
| +0.4% | +$6.01K | 0.42% | 57 |
|
|
2023
Q4 | $1.39M | Sell |
8,991
-95
| -1% | -$14.7K | 0.36% | 62 |
|
|
2023
Q3 | $1.35M | Buy |
9,086
+4
| +0% | +$596 | 0.45% | 45 |
|
|
2023
Q2 | $1.22M | Sell |
9,082
-85
| -0.9% | -$11.5K | 0.4% | 50 |
|
|
2023
Q1 | $1.46M | Buy |
9,167
+5
| +0.1% | +$797 | 0.51% | 44 |
|
|
2022
Q4 | $1.48M | Sell |
9,162
-8
| -0.1% | -$1.29K | 0.52% | 43 |
|
|
2022
Q3 | $1.23M | Buy |
9,170
+445
| +5% | +$59.7K | 0.48% | 42 |
|
|
2022
Q2 | $1.34M | Buy |
8,725
+4
| +0% | +$612 | 0.5% | 38 |
|
|
2022
Q1 | $1.41M | Sell |
8,721
-39
| -0.4% | -$6.32K | 0.48% | 38 |
|
|
2021
Q4 | $1.19M | Buy |
8,760
+5
| +0.1% | +$677 | 0.39% | 41 |
|
|
2021
Q3 | $944K | Buy |
8,755
+5
| +0.1% | +$539 | 0.34% | 48 |
|
|
2021
Q2 | $986K | Buy |
8,750
+4
| +0% | +$451 | 0.36% | 48 |
|
|
2021
Q1 | $946K | Buy |
8,746
+5
| +0.1% | +$541 | 0.37% | 45 |
|
|
2020
Q4 | $937K | Buy |
8,741
+5
| +0.1% | +$536 | 0.39% | 41 |
|
|
2020
Q3 | $765K | Buy |
8,736
+3
| +0% | +$263 | 0.36% | 41 |
|
|
2020
Q2 | $857K | Buy |
8,733
+8
| +0.1% | +$785 | 0.43% | 32 |
|
|
2020
Q1 | $665K | Buy |
8,725
+5
| +0.1% | +$381 | 0.38% | 37 |
|
|
2019
Q4 | $772K | Buy |
8,720
+4
| +0% | +$354 | 0.38% | 44 |
|
|
2019
Q3 | $660K | Buy |
8,716
+7
| +0.1% | +$530 | 0.34% | 44 |
|
|
2019
Q2 | $633K | Buy |
8,709
+48
| +0.6% | +$3.49K | 0.34% | 42 |
|
|
2019
Q1 | $698K | Buy |
8,661
+5
| +0.1% | +$403 | 0.38% | 41 |
|
|
2018
Q4 | $798K | Buy |
+8,656
| New | +$798K | 0.49% | 32 |
|